News

January 16, 2019

Triple Combination Works Well in Recurrent Ovarian Cancer with Smaller Tumors, Study Shows

News

The size of tumors in patients with recurrent ovarian cancer seems to predict responses to a triple combination treatment composed of IMV‘s lead candidate DPX-Survivac, Incyte’s experimental epacadostat, and low-dose chemotherapy, a ... Read more

January 14, 2019January 15, 2019

Talc May Be Tied to Ovarian Cancer and Serious Lung Problems, Health Canada Warns

News

The Canadian government is warning that exposure of the female genital area to talc-containing products may be associated with ovarian cancer and that inhalation of loose talc powder may lead to potentially ... Read more

January 11, 2019

New Steps Through OC Pilot Program Offers Support to Ovarian Cancer Patients and Caregivers

News

Aimed at easing the multifaceted impact of ovarian cancer diagnoses, a new national support initiative called Steps Through OC has unveiled its pilot program for women and their families. ... Read more

January 9, 2019

4 New Research Grants to Promote Study of Tumor Treating Fields as Cancer Therapy

News

In a collaborative effort to support and advance innovative research on Tumor Treating Fields (TTFields) — a therapy that uses electric fields to promote cell death — the oncology company ... Read more

January 7, 2019

BRACAnalysis CDx Approved in US as Companion Diagnostic Test for First-line Lynparza Treatment

News

Myriad Genetics‘ BRACAnalysis CDx has been approved by the U.S. Food and Drug Administration as a companion diagnostic test to identify women with ovarian cancer eligible for first-line maintenance treatment with Lynparza ... Read more

January 4, 2019

Lynparza Approved in U.S. as First-line Maintenance Therapy for BRCA-positive Advanced Ovarian Cancer

News

Women with BRCA-mutated advanced ovarian cancer living in the United States can now receive Lynparza (olaparib), developed by AstraZeneca and Merck, as a maintenance treatment for their partial or complete response to ... Read more

January 2, 2019

Newk’s Cares Campaign to Battle Ovarian Cancer Enters Fifth Year

News

Hoping to improve the rate of early ovarian cancer diagnoses by supporting early detection through symptom awareness and research funding, Newk’s Cares enters its fifth year having raised more than ... Read more

December 17, 2018

Bacterial Toxin-based Test Could Help Detect Ovarian Cancer Early

News

A bacterial toxin-based blood test could help in the early detection of ovarian cancer, and function as a tool for monitoring treatment and disease progression in patients with advanced ... Read more

December 14, 2018

Stanford Pursues New Research to Understand Spread and Resistance of Aggressive Ovarian Cancer

News

A team led by researchers at Stanford University will test an approach combining new materials and imaging technologies to provide a deeper understanding of how high-grade serous ovarian cancer develops. The condition ... Read more

News

Triple Combination Works Well in Recurrent Ovarian Cancer with Smaller Tumors, Study Shows

Talc May Be Tied to Ovarian Cancer and Serious Lung Problems, Health Canada Warns

New Steps Through OC Pilot Program Offers Support to Ovarian Cancer Patients and Caregivers

4 New Research Grants to Promote Study of Tumor Treating Fields as Cancer Therapy

BRACAnalysis CDx Approved in US as Companion Diagnostic Test for First-line Lynparza Treatment

Lynparza Approved in U.S. as First-line Maintenance Therapy for BRCA-positive Advanced Ovarian Cancer

Top 10 Ovarian Cancer Stories of 2018

Newk’s Cares Campaign to Battle Ovarian Cancer Enters Fifth Year

Bacterial Toxin-based Test Could Help Detect Ovarian Cancer Early

Stanford Pursues New Research to Understand Spread and Resistance of Aggressive Ovarian Cancer

Pin It on Pinterest